Publication & Citation Trends
Most Cited Works
Publications
150 total
Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening PDF
Cited by 693
OpenAlex
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
Cited by 912
OpenAlex
Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5
Cited by 556
OpenAlex
CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions
Cited by 396
OpenAlex
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
Cited by 1,424
OpenAlex
Studying clonal dynamics in response to cancer therapy using high-complexity barcoding
Cited by 524
OpenAlex
Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers PDF
Cited by 410
OpenAlex
Research Topics
Monoclonal and Polyclonal Antibodies Research
(26)
Immunotherapy and Immune Responses
(21)
CRISPR and Genetic Engineering
(18)
Cancer Mechanisms and Therapy
(18)
Microtubule and mitosis dynamics
(17)
Frequent Co-Authors
Affiliations
AstraZeneca (United Kingdom)
Novartis (Switzerland)
Foundation for Biomedical Research
University of Leeds
Boston Biomedical Research Institute